Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Whitbread appoints Severn Trent's Hodgson as its new chair

(Sharecast News) - Premier Inn owner Whitbread announced the appointment of Christine Hodgson as its next chair on Tuesday, effective 1 September. She would succeed Adam Crozier, who would step down and retire from the board on the same date after serving as chair for seven years.

The FTSE 100 hospitality company credited Crozier with guiding Whitbread through a period of strategic transformation, during which it sharpened its focus on becoming Europe's leading budget hotel operator.

Hodgson currently serves as chair of Severn Trent, and had senior leadership roles across technology and consumer-facing sectors, including with high-growth international businesses.

Whitbread said her experience would be instrumental as the group continued to deliver on its five-year plan and accelerated the expansion of Premier Inn in Germany.

The appointment followed a selection process led by senior independent director Richard Gillingwater, who said Hodgson would be an "outstanding" successor.

Hodgson said she was honoured to take on the role at what she described as an exciting time for the company.

"It has been a privilege to lead the Whitbread board through this period of growth and change," commented outgoing chair Adam Crozier.

"I'm proud that as I leave the business, we are on course for Premier Inn to become Europe's number one budget hotel business.

"I want to thank my colleagues on the board, and the whole Whitbread team, for their support during my time as chair, and wish Christine and everyone in the business every success in the future."

At 0857 BST, shares in Whitbread were up 1.07% at 2,830p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.